nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—breast cancer—ovarian cancer	0.388	1	CtDrD
Gemcitabine—TYMS—ovarian cancer	0.189	0.798	CbGaD
Gemcitabine—ABCC10—Paclitaxel—ovarian cancer	0.058	0.358	CbGbCtD
Gemcitabine—ABCB1—ovarian cancer	0.0478	0.202	CbGaD
Gemcitabine—ABCC10—Docetaxel—ovarian cancer	0.0419	0.259	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—ovarian cancer	0.0313	0.193	CbGbCtD
Gemcitabine—ABCB1—Topotecan—ovarian cancer	0.0109	0.0674	CbGbCtD
Gemcitabine—ABCB1—Vinorelbine—ovarian cancer	0.00769	0.0475	CbGbCtD
Gemcitabine—ABCB1—Paclitaxel—ovarian cancer	0.0054	0.0334	CbGbCtD
Gemcitabine—ABCB1—Docetaxel—ovarian cancer	0.00391	0.0241	CbGbCtD
Gemcitabine—POLD1—oviduct—ovarian cancer	0.00325	0.0638	CbGeAlD
Gemcitabine—ABCB1—Doxorubicin—ovarian cancer	0.00291	0.018	CbGbCtD
Gemcitabine—Lamivudine—NME2—ovarian cancer	0.00193	0.947	CrCbGaD
Gemcitabine—POLD1—uterine cervix—ovarian cancer	0.00081	0.0159	CbGeAlD
Gemcitabine—POLE—myometrium—ovarian cancer	0.000778	0.0153	CbGeAlD
Gemcitabine—POLE—embryo—ovarian cancer	0.000749	0.0147	CbGeAlD
Gemcitabine—CDA—uterine cervix—ovarian cancer	0.000727	0.0143	CbGeAlD
Gemcitabine—CDA—decidua—ovarian cancer	0.000693	0.0136	CbGeAlD
Gemcitabine—POLD1—gonad—ovarian cancer	0.00068	0.0133	CbGeAlD
Gemcitabine—POLD1—uterus—ovarian cancer	0.000675	0.0132	CbGeAlD
Gemcitabine—POLA1—myometrium—ovarian cancer	0.000671	0.0132	CbGeAlD
Gemcitabine—CDA—endometrium—ovarian cancer	0.000658	0.0129	CbGeAlD
Gemcitabine—CMPK1—uterine cervix—ovarian cancer	0.000646	0.0127	CbGeAlD
Gemcitabine—RRM2—myometrium—ovarian cancer	0.000641	0.0126	CbGeAlD
Gemcitabine—RRM2—embryo—ovarian cancer	0.000616	0.0121	CbGeAlD
Gemcitabine—CMPK1—decidua—ovarian cancer	0.000616	0.0121	CbGeAlD
Gemcitabine—POLD1—female reproductive system—ovarian cancer	0.000607	0.0119	CbGeAlD
Gemcitabine—POLE—uterine cervix—ovarian cancer	0.000606	0.0119	CbGeAlD
Gemcitabine—POLE—decidua—ovarian cancer	0.000577	0.0113	CbGeAlD
Gemcitabine—POLD1—female gonad—ovarian cancer	0.000552	0.0108	CbGeAlD
Gemcitabine—POLE—endometrium—ovarian cancer	0.000548	0.0107	CbGeAlD
Gemcitabine—CMPK1—gonad—ovarian cancer	0.000542	0.0106	CbGeAlD
Gemcitabine—CMPK1—uterus—ovarian cancer	0.000539	0.0106	CbGeAlD
Gemcitabine—RRM1—myometrium—ovarian cancer	0.000532	0.0104	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—ovarian cancer	0.000526	0.0103	CbGeAlD
Gemcitabine—POLA1—uterine cervix—ovarian cancer	0.000522	0.0102	CbGeAlD
Gemcitabine—CDA—bone marrow—ovarian cancer	0.000514	0.0101	CbGeAlD
Gemcitabine—SLC29A2—female reproductive system—ovarian cancer	0.000509	0.00998	CbGeAlD
Gemcitabine—POLE—gonad—ovarian cancer	0.000508	0.00996	CbGeAlD
Gemcitabine—SLC28A3—female gonad—ovarian cancer	0.000507	0.00993	CbGeAlD
Gemcitabine—RRM2—uterine cervix—ovarian cancer	0.000499	0.00978	CbGeAlD
Gemcitabine—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.000498	0.291	CbGdCrCtD
Gemcitabine—POLA1—decidua—ovarian cancer	0.000497	0.00975	CbGeAlD
Gemcitabine—CDA—vagina—ovarian cancer	0.000493	0.00966	CbGeAlD
Gemcitabine—POLD1—testis—ovarian cancer	0.00049	0.0096	CbGeAlD
Gemcitabine—CMPK1—female reproductive system—ovarian cancer	0.000484	0.0095	CbGeAlD
Gemcitabine—RRM2—decidua—ovarian cancer	0.000475	0.00932	CbGeAlD
Gemcitabine—POLA1—endometrium—ovarian cancer	0.000472	0.00926	CbGeAlD
Gemcitabine—SLC29A2—vagina—ovarian cancer	0.00046	0.00903	CbGeAlD
Gemcitabine—CMPK1—bone marrow—ovarian cancer	0.000457	0.00896	CbGeAlD
Gemcitabine—POLE—female reproductive system—ovarian cancer	0.000454	0.0089	CbGeAlD
Gemcitabine—RRM2—endometrium—ovarian cancer	0.000451	0.00884	CbGeAlD
Gemcitabine—POLA1—Vinblastine—Vinorelbine—ovarian cancer	0.000443	0.259	CbGdCrCtD
Gemcitabine—CMPK1—female gonad—ovarian cancer	0.000441	0.00864	CbGeAlD
Gemcitabine—CDA—testis—ovarian cancer	0.00044	0.00862	CbGeAlD
Gemcitabine—CMPK1—vagina—ovarian cancer	0.000438	0.00859	CbGeAlD
Gemcitabine—SLC29A1—myometrium—ovarian cancer	0.000433	0.00849	CbGeAlD
Gemcitabine—POLE—bone marrow—ovarian cancer	0.000428	0.0084	CbGeAlD
Gemcitabine—RRM2—gonad—ovarian cancer	0.000418	0.0082	CbGeAlD
Gemcitabine—RRM2—uterus—ovarian cancer	0.000416	0.00815	CbGeAlD
Gemcitabine—RRM1—uterine cervix—ovarian cancer	0.000414	0.00812	CbGeAlD
Gemcitabine—DCK—myometrium—ovarian cancer	0.000414	0.00811	CbGeAlD
Gemcitabine—POLE—female gonad—ovarian cancer	0.000413	0.0081	CbGeAlD
Gemcitabine—POLE—vagina—ovarian cancer	0.00041	0.00805	CbGeAlD
Gemcitabine—DCK—embryo—ovarian cancer	0.000398	0.0078	CbGeAlD
Gemcitabine—RRM1—decidua—ovarian cancer	0.000395	0.00774	CbGeAlD
Gemcitabine—ABCC10—myometrium—ovarian cancer	0.000394	0.00773	CbGeAlD
Gemcitabine—CMPK1—testis—ovarian cancer	0.000391	0.00766	CbGeAlD
Gemcitabine—TYMS—uterine cervix—ovarian cancer	0.000376	0.00737	CbGeAlD
Gemcitabine—RRM1—endometrium—ovarian cancer	0.000375	0.00735	CbGeAlD
Gemcitabine—RRM2—female reproductive system—ovarian cancer	0.000374	0.00733	CbGeAlD
Gemcitabine—POLA1—bone marrow—ovarian cancer	0.000369	0.00724	CbGeAlD
Gemcitabine—POLE—testis—ovarian cancer	0.000366	0.00718	CbGeAlD
Gemcitabine—POLA1—female gonad—ovarian cancer	0.000356	0.00698	CbGeAlD
Gemcitabine—POLD1—lymph node—ovarian cancer	0.000355	0.00696	CbGeAlD
Gemcitabine—POLA1—vagina—ovarian cancer	0.000354	0.00694	CbGeAlD
Gemcitabine—RRM2—bone marrow—ovarian cancer	0.000353	0.00692	CbGeAlD
Gemcitabine—RRM1—gonad—ovarian cancer	0.000348	0.00682	CbGeAlD
Gemcitabine—RRM1—uterus—ovarian cancer	0.000345	0.00677	CbGeAlD
Gemcitabine—RRM2—female gonad—ovarian cancer	0.00034	0.00667	CbGeAlD
Gemcitabine—TYMS—endometrium—ovarian cancer	0.00034	0.00666	CbGeAlD
Gemcitabine—RRM2—vagina—ovarian cancer	0.000338	0.00663	CbGeAlD
Gemcitabine—SLC29A1—uterine cervix—ovarian cancer	0.000337	0.00661	CbGeAlD
Gemcitabine—DCK—uterine cervix—ovarian cancer	0.000322	0.00631	CbGeAlD
Gemcitabine—SLC29A1—decidua—ovarian cancer	0.000321	0.00629	CbGeAlD
Gemcitabine—CDA—lymph node—ovarian cancer	0.000319	0.00625	CbGeAlD
Gemcitabine—POLA1—testis—ovarian cancer	0.000316	0.00619	CbGeAlD
Gemcitabine—TYMS—gonad—ovarian cancer	0.000315	0.00618	CbGeAlD
Gemcitabine—RRM1—female reproductive system—ovarian cancer	0.00031	0.00609	CbGeAlD
Gemcitabine—DCK—decidua—ovarian cancer	0.000307	0.00601	CbGeAlD
Gemcitabine—ABCC10—uterine cervix—ovarian cancer	0.000307	0.00601	CbGeAlD
Gemcitabine—SLC29A1—endometrium—ovarian cancer	0.000305	0.00597	CbGeAlD
Gemcitabine—RRM2—testis—ovarian cancer	0.000302	0.00591	CbGeAlD
Gemcitabine—SLC29A2—lymph node—ovarian cancer	0.000298	0.00584	CbGeAlD
Gemcitabine—RRM1—bone marrow—ovarian cancer	0.000293	0.00575	CbGeAlD
Gemcitabine—ABCC10—decidua—ovarian cancer	0.000292	0.00573	CbGeAlD
Gemcitabine—DCK—endometrium—ovarian cancer	0.000291	0.00571	CbGeAlD
Gemcitabine—CMPK1—lymph node—ovarian cancer	0.000283	0.00555	CbGeAlD
Gemcitabine—SLC29A1—gonad—ovarian cancer	0.000283	0.00554	CbGeAlD
Gemcitabine—RRM1—female gonad—ovarian cancer	0.000282	0.00554	CbGeAlD
Gemcitabine—TYMS—female reproductive system—ovarian cancer	0.000281	0.00552	CbGeAlD
Gemcitabine—SLC29A1—uterus—ovarian cancer	0.000281	0.00551	CbGeAlD
Gemcitabine—RRM1—vagina—ovarian cancer	0.000281	0.00551	CbGeAlD
Gemcitabine—ABCC10—endometrium—ovarian cancer	0.000277	0.00544	CbGeAlD
Gemcitabine—DCK—gonad—ovarian cancer	0.00027	0.00529	CbGeAlD
Gemcitabine—DCK—uterus—ovarian cancer	0.000268	0.00526	CbGeAlD
Gemcitabine—TYMS—bone marrow—ovarian cancer	0.000266	0.00521	CbGeAlD
Gemcitabine—POLE—lymph node—ovarian cancer	0.000265	0.0052	CbGeAlD
Gemcitabine—ABCC10—gonad—ovarian cancer	0.000257	0.00504	CbGeAlD
Gemcitabine—TYMS—female gonad—ovarian cancer	0.000256	0.00502	CbGeAlD
Gemcitabine—ABCC10—uterus—ovarian cancer	0.000256	0.00501	CbGeAlD
Gemcitabine—TYMS—vagina—ovarian cancer	0.000255	0.00499	CbGeAlD
Gemcitabine—SLC29A1—female reproductive system—ovarian cancer	0.000252	0.00495	CbGeAlD
Gemcitabine—RRM1—testis—ovarian cancer	0.000251	0.00491	CbGeAlD
Gemcitabine—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.000249	0.145	CbGdCrCtD
Gemcitabine—DCK—female reproductive system—ovarian cancer	0.000241	0.00473	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—ovarian cancer	0.000238	0.00467	CbGeAlD
Gemcitabine—ABCC10—female reproductive system—ovarian cancer	0.00023	0.0045	CbGeAlD
Gemcitabine—SLC29A1—female gonad—ovarian cancer	0.00023	0.0045	CbGeAlD
Gemcitabine—POLA1—lymph node—ovarian cancer	0.000229	0.00449	CbGeAlD
Gemcitabine—SLC29A1—vagina—ovarian cancer	0.000228	0.00448	CbGeAlD
Gemcitabine—DCK—bone marrow—ovarian cancer	0.000228	0.00446	CbGeAlD
Gemcitabine—TYMS—testis—ovarian cancer	0.000227	0.00445	CbGeAlD
Gemcitabine—DCK—female gonad—ovarian cancer	0.000219	0.0043	CbGeAlD
Gemcitabine—RRM2—lymph node—ovarian cancer	0.000219	0.00429	CbGeAlD
Gemcitabine—DCK—vagina—ovarian cancer	0.000218	0.00428	CbGeAlD
Gemcitabine—ABCC10—bone marrow—ovarian cancer	0.000217	0.00425	CbGeAlD
Gemcitabine—ABCC10—female gonad—ovarian cancer	0.000209	0.0041	CbGeAlD
Gemcitabine—ABCC10—vagina—ovarian cancer	0.000208	0.00407	CbGeAlD
Gemcitabine—SLC29A1—testis—ovarian cancer	0.000204	0.00399	CbGeAlD
Gemcitabine—DCK—testis—ovarian cancer	0.000195	0.00382	CbGeAlD
Gemcitabine—ABCC10—testis—ovarian cancer	0.000185	0.00364	CbGeAlD
Gemcitabine—RRM1—lymph node—ovarian cancer	0.000182	0.00356	CbGeAlD
Gemcitabine—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000171	0.0999	CbGdCrCtD
Gemcitabine—TYMS—lymph node—ovarian cancer	0.000165	0.00323	CbGeAlD
Gemcitabine—SLC29A1—lymph node—ovarian cancer	0.000148	0.0029	CbGeAlD
Gemcitabine—DCK—lymph node—ovarian cancer	0.000141	0.00277	CbGeAlD
Gemcitabine—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.000138	0.0803	CbGdCrCtD
Gemcitabine—ABCC10—lymph node—ovarian cancer	0.000134	0.00264	CbGeAlD
Gemcitabine—ABCB1—myometrium—ovarian cancer	0.000114	0.00223	CbGeAlD
Gemcitabine—DCK—Doxorubicin—Epirubicin—ovarian cancer	0.000111	0.0647	CbGdCrCtD
Gemcitabine—ABCB1—embryo—ovarian cancer	0.000109	0.00215	CbGeAlD
Gemcitabine—Lamivudine—ABCB1—ovarian cancer	0.000108	0.0528	CrCbGaD
Gemcitabine—DCK—Epirubicin—Doxorubicin—ovarian cancer	0.000102	0.0598	CbGdCrCtD
Gemcitabine—ABCB1—epithelium—ovarian cancer	8.93e-05	0.00175	CbGeAlD
Gemcitabine—ABCB1—uterine cervix—ovarian cancer	8.85e-05	0.00174	CbGeAlD
Gemcitabine—ABCB1—decidua—ovarian cancer	8.44e-05	0.00165	CbGeAlD
Gemcitabine—ABCB1—endometrium—ovarian cancer	8.01e-05	0.00157	CbGeAlD
Gemcitabine—ABCB1—gonad—ovarian cancer	7.43e-05	0.00146	CbGeAlD
Gemcitabine—ABCB1—uterus—ovarian cancer	7.38e-05	0.00145	CbGeAlD
Gemcitabine—ABCB1—female reproductive system—ovarian cancer	6.63e-05	0.0013	CbGeAlD
Gemcitabine—ABCB1—bone marrow—ovarian cancer	6.26e-05	0.00123	CbGeAlD
Gemcitabine—ABCB1—female gonad—ovarian cancer	6.04e-05	0.00118	CbGeAlD
Gemcitabine—ABCB1—vagina—ovarian cancer	6e-05	0.00118	CbGeAlD
Gemcitabine—ABCB1—testis—ovarian cancer	5.35e-05	0.00105	CbGeAlD
Gemcitabine—Dermatitis—Topotecan—ovarian cancer	4.57e-05	0.000477	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—ovarian cancer	4.55e-05	0.000475	CcSEcCtD
Gemcitabine—Headache—Topotecan—ovarian cancer	4.55e-05	0.000474	CcSEcCtD
Gemcitabine—Angiopathy—Docetaxel—ovarian cancer	4.52e-05	0.000472	CcSEcCtD
Gemcitabine—Vomiting—Melphalan—ovarian cancer	4.52e-05	0.000472	CcSEcCtD
Gemcitabine—Immune system disorder—Docetaxel—ovarian cancer	4.5e-05	0.00047	CcSEcCtD
Gemcitabine—Mediastinal disorder—Docetaxel—ovarian cancer	4.49e-05	0.000469	CcSEcCtD
Gemcitabine—Liver function test abnormal—Epirubicin—ovarian cancer	4.49e-05	0.000468	CcSEcCtD
Gemcitabine—Rash—Melphalan—ovarian cancer	4.48e-05	0.000468	CcSEcCtD
Gemcitabine—Dermatitis—Melphalan—ovarian cancer	4.48e-05	0.000467	CcSEcCtD
Gemcitabine—Chills—Docetaxel—ovarian cancer	4.47e-05	0.000466	CcSEcCtD
Gemcitabine—Cough—Paclitaxel—ovarian cancer	4.47e-05	0.000466	CcSEcCtD
Gemcitabine—Asthenia—Vinorelbine—ovarian cancer	4.46e-05	0.000465	CcSEcCtD
Gemcitabine—Arrhythmia—Docetaxel—ovarian cancer	4.45e-05	0.000464	CcSEcCtD
Gemcitabine—Hypokalaemia—Epirubicin—ovarian cancer	4.42e-05	0.000461	CcSEcCtD
Gemcitabine—Hypertension—Paclitaxel—ovarian cancer	4.42e-05	0.000461	CcSEcCtD
Gemcitabine—Alopecia—Docetaxel—ovarian cancer	4.41e-05	0.000459	CcSEcCtD
Gemcitabine—Pruritus—Vinorelbine—ovarian cancer	4.4e-05	0.000458	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	4.38e-05	0.000456	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	4.38e-05	0.000456	CcSEcCtD
Gemcitabine—Chest pain—Paclitaxel—ovarian cancer	4.36e-05	0.000455	CcSEcCtD
Gemcitabine—Myalgia—Paclitaxel—ovarian cancer	4.36e-05	0.000455	CcSEcCtD
Gemcitabine—Arthralgia—Paclitaxel—ovarian cancer	4.36e-05	0.000455	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—ovarian cancer	4.34e-05	0.000453	CcSEcCtD
Gemcitabine—Erythema—Docetaxel—ovarian cancer	4.34e-05	0.000453	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	4.33e-05	0.000451	CcSEcCtD
Gemcitabine—Nausea—Topotecan—ovarian cancer	4.31e-05	0.00045	CcSEcCtD
Gemcitabine—Discomfort—Paclitaxel—ovarian cancer	4.31e-05	0.000449	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	4.29e-05	0.000447	CcSEcCtD
Gemcitabine—Diarrhoea—Vinorelbine—ovarian cancer	4.25e-05	0.000443	CcSEcCtD
Gemcitabine—Nausea—Melphalan—ovarian cancer	4.22e-05	0.00044	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—ovarian cancer	4.21e-05	0.000439	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—ovarian cancer	4.2e-05	0.000438	CcSEcCtD
Gemcitabine—Back pain—Docetaxel—ovarian cancer	4.2e-05	0.000438	CcSEcCtD
Gemcitabine—Oedema—Paclitaxel—ovarian cancer	4.18e-05	0.000436	CcSEcCtD
Gemcitabine—Anaphylactic shock—Paclitaxel—ovarian cancer	4.18e-05	0.000436	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—ovarian cancer	4.15e-05	0.000433	CcSEcCtD
Gemcitabine—Infection—Paclitaxel—ovarian cancer	4.15e-05	0.000433	CcSEcCtD
Gemcitabine—Nervous system disorder—Paclitaxel—ovarian cancer	4.1e-05	0.000427	CcSEcCtD
Gemcitabine—Hypokalaemia—Doxorubicin—ovarian cancer	4.09e-05	0.000427	CcSEcCtD
Gemcitabine—Thrombocytopenia—Paclitaxel—ovarian cancer	4.09e-05	0.000427	CcSEcCtD
Gemcitabine—Skin disorder—Paclitaxel—ovarian cancer	4.06e-05	0.000423	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	4.05e-05	0.000422	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	4.05e-05	0.000422	CcSEcCtD
Gemcitabine—Hyperhidrosis—Paclitaxel—ovarian cancer	4.04e-05	0.000421	CcSEcCtD
Gemcitabine—Anaemia—Docetaxel—ovarian cancer	4.01e-05	0.000418	CcSEcCtD
Gemcitabine—Pancytopenia—Epirubicin—ovarian cancer	3.99e-05	0.000416	CcSEcCtD
Gemcitabine—Anorexia—Paclitaxel—ovarian cancer	3.98e-05	0.000415	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	3.97e-05	0.000414	CcSEcCtD
Gemcitabine—Vomiting—Vinorelbine—ovarian cancer	3.95e-05	0.000412	CcSEcCtD
Gemcitabine—Neutropenia—Epirubicin—ovarian cancer	3.93e-05	0.00041	CcSEcCtD
Gemcitabine—Rash—Vinorelbine—ovarian cancer	3.92e-05	0.000409	CcSEcCtD
Gemcitabine—Dermatitis—Vinorelbine—ovarian cancer	3.91e-05	0.000408	CcSEcCtD
Gemcitabine—Hypotension—Paclitaxel—ovarian cancer	3.9e-05	0.000407	CcSEcCtD
Gemcitabine—Headache—Vinorelbine—ovarian cancer	3.89e-05	0.000406	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—ovarian cancer	3.89e-05	0.000405	CcSEcCtD
Gemcitabine—Leukopenia—Docetaxel—ovarian cancer	3.88e-05	0.000405	CcSEcCtD
Gemcitabine—ABCB1—lymph node—ovarian cancer	3.88e-05	0.000761	CbGeAlD
Gemcitabine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	3.81e-05	0.000397	CcSEcCtD
Gemcitabine—Hyperglycaemia—Epirubicin—ovarian cancer	3.79e-05	0.000395	CcSEcCtD
Gemcitabine—Cough—Docetaxel—ovarian cancer	3.79e-05	0.000395	CcSEcCtD
Gemcitabine—Insomnia—Paclitaxel—ovarian cancer	3.78e-05	0.000394	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—ovarian cancer	3.77e-05	0.000393	CcSEcCtD
Gemcitabine—Paraesthesia—Paclitaxel—ovarian cancer	3.75e-05	0.000391	CcSEcCtD
Gemcitabine—Hypertension—Docetaxel—ovarian cancer	3.75e-05	0.000391	CcSEcCtD
Gemcitabine—Dyspnoea—Paclitaxel—ovarian cancer	3.73e-05	0.000389	CcSEcCtD
Gemcitabine—Somnolence—Paclitaxel—ovarian cancer	3.71e-05	0.000387	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	3.71e-05	0.000387	CcSEcCtD
Gemcitabine—Myalgia—Docetaxel—ovarian cancer	3.69e-05	0.000385	CcSEcCtD
Gemcitabine—Chest pain—Docetaxel—ovarian cancer	3.69e-05	0.000385	CcSEcCtD
Gemcitabine—Arthralgia—Docetaxel—ovarian cancer	3.69e-05	0.000385	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—ovarian cancer	3.69e-05	0.000385	CcSEcCtD
Gemcitabine—Nausea—Vinorelbine—ovarian cancer	3.69e-05	0.000385	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—ovarian cancer	3.68e-05	0.000384	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—ovarian cancer	3.67e-05	0.000383	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	3.67e-05	0.000383	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—ovarian cancer	3.65e-05	0.000381	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—ovarian cancer	3.63e-05	0.000379	CcSEcCtD
Gemcitabine—Decreased appetite—Paclitaxel—ovarian cancer	3.63e-05	0.000379	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	3.61e-05	0.000376	CcSEcCtD
Gemcitabine—Fatigue—Paclitaxel—ovarian cancer	3.6e-05	0.000376	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—ovarian cancer	3.59e-05	0.000374	CcSEcCtD
Gemcitabine—Pain—Paclitaxel—ovarian cancer	3.57e-05	0.000373	CcSEcCtD
Gemcitabine—Constipation—Paclitaxel—ovarian cancer	3.57e-05	0.000373	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—ovarian cancer	3.57e-05	0.000372	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—ovarian cancer	3.54e-05	0.000369	CcSEcCtD
Gemcitabine—Oedema—Docetaxel—ovarian cancer	3.54e-05	0.000369	CcSEcCtD
Gemcitabine—Anaphylactic shock—Docetaxel—ovarian cancer	3.54e-05	0.000369	CcSEcCtD
Gemcitabine—Infection—Docetaxel—ovarian cancer	3.52e-05	0.000367	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—ovarian cancer	3.51e-05	0.000366	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—ovarian cancer	3.5e-05	0.000365	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—ovarian cancer	3.49e-05	0.000364	CcSEcCtD
Gemcitabine—Nervous system disorder—Docetaxel—ovarian cancer	3.47e-05	0.000362	CcSEcCtD
Gemcitabine—Thrombocytopenia—Docetaxel—ovarian cancer	3.47e-05	0.000362	CcSEcCtD
Gemcitabine—Feeling abnormal—Paclitaxel—ovarian cancer	3.44e-05	0.000359	CcSEcCtD
Gemcitabine—Skin disorder—Docetaxel—ovarian cancer	3.44e-05	0.000359	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	3.44e-05	0.000358	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—ovarian cancer	3.41e-05	0.000355	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—ovarian cancer	3.4e-05	0.000354	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—ovarian cancer	3.38e-05	0.000352	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—ovarian cancer	3.38e-05	0.000352	CcSEcCtD
Gemcitabine—Anorexia—Docetaxel—ovarian cancer	3.38e-05	0.000352	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—ovarian cancer	3.37e-05	0.000352	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—ovarian cancer	3.36e-05	0.000351	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—ovarian cancer	3.34e-05	0.000348	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—ovarian cancer	3.32e-05	0.000347	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—ovarian cancer	3.32e-05	0.000346	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—ovarian cancer	3.31e-05	0.000345	CcSEcCtD
Gemcitabine—Hypotension—Docetaxel—ovarian cancer	3.31e-05	0.000345	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—ovarian cancer	3.3e-05	0.000345	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—ovarian cancer	3.3e-05	0.000345	CcSEcCtD
Gemcitabine—Body temperature increased—Paclitaxel—ovarian cancer	3.3e-05	0.000344	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—ovarian cancer	3.3e-05	0.000344	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—ovarian cancer	3.28e-05	0.000342	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—ovarian cancer	3.23e-05	0.000337	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	3.23e-05	0.000337	CcSEcCtD
Gemcitabine—Insomnia—Docetaxel—ovarian cancer	3.2e-05	0.000334	CcSEcCtD
Gemcitabine—Paraesthesia—Docetaxel—ovarian cancer	3.18e-05	0.000332	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—ovarian cancer	3.18e-05	0.000332	CcSEcCtD
Gemcitabine—Dyspnoea—Docetaxel—ovarian cancer	3.16e-05	0.000329	CcSEcCtD
Gemcitabine—Somnolence—Docetaxel—ovarian cancer	3.15e-05	0.000328	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—ovarian cancer	3.13e-05	0.000326	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—ovarian cancer	3.12e-05	0.000325	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—ovarian cancer	3.12e-05	0.000325	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—ovarian cancer	3.11e-05	0.000324	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—ovarian cancer	3.09e-05	0.000322	CcSEcCtD
Gemcitabine—Decreased appetite—Docetaxel—ovarian cancer	3.08e-05	0.000321	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—ovarian cancer	3.07e-05	0.00032	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—ovarian cancer	3.06e-05	0.00032	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Docetaxel—ovarian cancer	3.06e-05	0.000319	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—ovarian cancer	3.06e-05	0.000319	CcSEcCtD
Gemcitabine—Fatigue—Docetaxel—ovarian cancer	3.05e-05	0.000318	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—ovarian cancer	3.05e-05	0.000318	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—ovarian cancer	3.05e-05	0.000318	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—ovarian cancer	3.04e-05	0.000317	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—ovarian cancer	3.03e-05	0.000316	CcSEcCtD
Gemcitabine—Constipation—Docetaxel—ovarian cancer	3.03e-05	0.000316	CcSEcCtD
Gemcitabine—Pain—Docetaxel—ovarian cancer	3.03e-05	0.000316	CcSEcCtD
Gemcitabine—Chills—Epirubicin—ovarian cancer	3.02e-05	0.000315	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—ovarian cancer	3e-05	0.000313	CcSEcCtD
Gemcitabine—Asthenia—Paclitaxel—ovarian cancer	3e-05	0.000313	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—ovarian cancer	2.97e-05	0.00031	CcSEcCtD
Gemcitabine—Pruritus—Paclitaxel—ovarian cancer	2.96e-05	0.000308	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—ovarian cancer	2.94e-05	0.000307	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—ovarian cancer	2.93e-05	0.000305	CcSEcCtD
Gemcitabine—Feeling abnormal—Docetaxel—ovarian cancer	2.92e-05	0.000304	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—ovarian cancer	2.89e-05	0.000301	CcSEcCtD
Gemcitabine—Diarrhoea—Paclitaxel—ovarian cancer	2.86e-05	0.000298	CcSEcCtD
Gemcitabine—Back pain—Epirubicin—ovarian cancer	2.83e-05	0.000295	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—ovarian cancer	2.82e-05	0.000294	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—ovarian cancer	2.81e-05	0.000293	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—ovarian cancer	2.8e-05	0.000292	CcSEcCtD
Gemcitabine—Body temperature increased—Docetaxel—ovarian cancer	2.8e-05	0.000292	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—ovarian cancer	2.79e-05	0.000291	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—ovarian cancer	2.78e-05	0.00029	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—ovarian cancer	2.75e-05	0.000287	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—ovarian cancer	2.72e-05	0.000283	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—ovarian cancer	2.71e-05	0.000282	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—ovarian cancer	2.71e-05	0.000282	CcSEcCtD
Gemcitabine—Vomiting—Paclitaxel—ovarian cancer	2.66e-05	0.000277	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—ovarian cancer	2.64e-05	0.000275	CcSEcCtD
Gemcitabine—Rash—Paclitaxel—ovarian cancer	2.63e-05	0.000275	CcSEcCtD
Gemcitabine—Dermatitis—Paclitaxel—ovarian cancer	2.63e-05	0.000275	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—ovarian cancer	2.62e-05	0.000273	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—ovarian cancer	2.62e-05	0.000273	CcSEcCtD
Gemcitabine—Headache—Paclitaxel—ovarian cancer	2.62e-05	0.000273	CcSEcCtD
Gemcitabine—Cough—Epirubicin—ovarian cancer	2.55e-05	0.000266	CcSEcCtD
Gemcitabine—Asthenia—Docetaxel—ovarian cancer	2.54e-05	0.000265	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—ovarian cancer	2.53e-05	0.000264	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—ovarian cancer	2.51e-05	0.000262	CcSEcCtD
Gemcitabine—Pruritus—Docetaxel—ovarian cancer	2.51e-05	0.000261	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—ovarian cancer	2.5e-05	0.000261	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—ovarian cancer	2.49e-05	0.00026	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—ovarian cancer	2.49e-05	0.00026	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—ovarian cancer	2.49e-05	0.00026	CcSEcCtD
Gemcitabine—Nausea—Paclitaxel—ovarian cancer	2.48e-05	0.000259	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	2.47e-05	0.000258	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—ovarian cancer	2.46e-05	0.000257	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—ovarian cancer	2.44e-05	0.000255	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—ovarian cancer	2.42e-05	0.000253	CcSEcCtD
Gemcitabine—Diarrhoea—Docetaxel—ovarian cancer	2.42e-05	0.000253	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—ovarian cancer	2.39e-05	0.000249	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—ovarian cancer	2.39e-05	0.000249	CcSEcCtD
Gemcitabine—Infection—Epirubicin—ovarian cancer	2.37e-05	0.000248	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—ovarian cancer	2.36e-05	0.000246	CcSEcCtD
Gemcitabine—Nervous system disorder—Epirubicin—ovarian cancer	2.34e-05	0.000244	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—ovarian cancer	2.34e-05	0.000244	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—ovarian cancer	2.34e-05	0.000244	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—ovarian cancer	2.32e-05	0.000242	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—ovarian cancer	2.31e-05	0.000241	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—ovarian cancer	2.31e-05	0.00024	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—ovarian cancer	2.31e-05	0.00024	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—ovarian cancer	2.31e-05	0.00024	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	2.29e-05	0.000239	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—ovarian cancer	2.28e-05	0.000238	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—ovarian cancer	2.28e-05	0.000237	CcSEcCtD
Gemcitabine—Vomiting—Docetaxel—ovarian cancer	2.25e-05	0.000235	CcSEcCtD
Gemcitabine—Rash—Docetaxel—ovarian cancer	2.23e-05	0.000233	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—ovarian cancer	2.23e-05	0.000233	CcSEcCtD
Gemcitabine—Dermatitis—Docetaxel—ovarian cancer	2.23e-05	0.000233	CcSEcCtD
Gemcitabine—Headache—Docetaxel—ovarian cancer	2.22e-05	0.000231	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—ovarian cancer	2.21e-05	0.000231	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—ovarian cancer	2.21e-05	0.000231	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—ovarian cancer	2.2e-05	0.000229	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	2.18e-05	0.000227	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—ovarian cancer	2.17e-05	0.000226	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—ovarian cancer	2.16e-05	0.000226	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—ovarian cancer	2.16e-05	0.000225	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—ovarian cancer	2.15e-05	0.000224	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—ovarian cancer	2.15e-05	0.000224	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—ovarian cancer	2.14e-05	0.000223	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—ovarian cancer	2.13e-05	0.000222	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—ovarian cancer	2.12e-05	0.000221	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—ovarian cancer	2.11e-05	0.00022	CcSEcCtD
Gemcitabine—Nausea—Docetaxel—ovarian cancer	2.1e-05	0.000219	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—ovarian cancer	2.08e-05	0.000217	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—ovarian cancer	2.07e-05	0.000215	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—ovarian cancer	2.06e-05	0.000215	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—ovarian cancer	2.06e-05	0.000215	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—ovarian cancer	2.04e-05	0.000213	CcSEcCtD
Gemcitabine—Pain—Epirubicin—ovarian cancer	2.04e-05	0.000213	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	2.01e-05	0.00021	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—ovarian cancer	2e-05	0.000208	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—ovarian cancer	1.98e-05	0.000207	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—ovarian cancer	1.97e-05	0.000206	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—ovarian cancer	1.97e-05	0.000205	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—ovarian cancer	1.97e-05	0.000205	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—ovarian cancer	1.92e-05	0.0002	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.91e-05	0.000199	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—ovarian cancer	1.91e-05	0.000199	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—ovarian cancer	1.89e-05	0.000197	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—ovarian cancer	1.89e-05	0.000197	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—ovarian cancer	1.89e-05	0.000197	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—CCND2—ovarian cancer	1.83e-05	0.000292	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—ovarian cancer	1.82e-05	0.00019	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.82e-05	0.000289	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.81e-05	0.000288	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.81e-05	0.000287	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.8e-05	0.000286	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.77e-05	0.000282	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.76e-05	0.000281	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.76e-05	0.00028	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND2—ovarian cancer	1.76e-05	0.000279	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BRCA1—ovarian cancer	1.76e-05	0.000279	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—ovarian cancer	1.75e-05	0.000182	CcSEcCtD
Gemcitabine—CDA—Metabolism—PPP2R1A—ovarian cancer	1.74e-05	0.000277	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.74e-05	0.000277	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—PPP2R1A—ovarian cancer	1.73e-05	0.000275	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.72e-05	0.000274	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—ovarian cancer	1.71e-05	0.000179	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.7e-05	0.00027	CbGpPWpGaD
Gemcitabine—Pruritus—Epirubicin—ovarian cancer	1.69e-05	0.000176	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	1.69e-05	0.000269	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BRCA2—ovarian cancer	1.66e-05	0.000264	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CD—ovarian cancer	1.66e-05	0.000264	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	1.66e-05	0.000264	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—YAP1—ovarian cancer	1.65e-05	0.000262	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—YAP1—ovarian cancer	1.64e-05	0.000261	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—ovarian cancer	1.63e-05	0.00017	CcSEcCtD
Gemcitabine—RRM1—Metabolism—FASN—ovarian cancer	1.63e-05	0.00026	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	1.63e-05	0.000259	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCB1—ovarian cancer	1.62e-05	0.000257	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPP1CC—ovarian cancer	1.61e-05	0.000256	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BRIP1—ovarian cancer	1.61e-05	0.000256	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SLC5A5—ovarian cancer	1.61e-05	0.000256	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCNE1—ovarian cancer	1.61e-05	0.000255	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.6e-05	0.000254	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BRCA2—ovarian cancer	1.59e-05	0.000253	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TYMS—ovarian cancer	1.59e-05	0.000252	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.59e-05	0.000252	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—ovarian cancer	1.59e-05	0.000165	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—TYMS—ovarian cancer	1.58e-05	0.000251	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—ovarian cancer	1.56e-05	0.000163	CcSEcCtD
Gemcitabine—RRM1—Metabolism—SLC2A1—ovarian cancer	1.55e-05	0.000247	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—YAP1—ovarian cancer	1.54e-05	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCNE1—ovarian cancer	1.54e-05	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.53e-05	0.000244	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.52e-05	0.000242	CbGpPWpGaD
Gemcitabine—Vomiting—Epirubicin—ovarian cancer	1.52e-05	0.000158	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.51e-05	0.000241	CbGpPWpGaD
Gemcitabine—Diarrhoea—Doxorubicin—ovarian cancer	1.51e-05	0.000158	CcSEcCtD
Gemcitabine—Rash—Epirubicin—ovarian cancer	1.51e-05	0.000157	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—ovarian cancer	1.5e-05	0.000157	CcSEcCtD
Gemcitabine—Headache—Epirubicin—ovarian cancer	1.5e-05	0.000156	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CYP1B1—ovarian cancer	1.49e-05	0.000237	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.47e-05	0.000234	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	1.46e-05	0.000233	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.45e-05	0.000231	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CB—ovarian cancer	1.45e-05	0.00023	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.44e-05	0.000229	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.44e-05	0.000229	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BIRC5—ovarian cancer	1.42e-05	0.000226	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—ovarian cancer	1.42e-05	0.000148	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.41e-05	0.000224	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—ovarian cancer	1.41e-05	0.000147	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—ovarian cancer	1.39e-05	0.000145	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—ovarian cancer	1.39e-05	0.000145	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—ovarian cancer	1.38e-05	0.000144	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.38e-05	0.000219	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.38e-05	0.000219	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	1.38e-05	0.000219	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—ovarian cancer	1.37e-05	0.000219	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.36e-05	0.000216	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.36e-05	0.000216	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BIRC5—ovarian cancer	1.36e-05	0.000216	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.35e-05	0.000215	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—FASN—ovarian cancer	1.35e-05	0.000214	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—FASN—ovarian cancer	1.34e-05	0.000213	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	1.34e-05	0.000213	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC5A5—ovarian cancer	1.32e-05	0.00021	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPP2R1A—ovarian cancer	1.32e-05	0.00021	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—ovarian cancer	1.32e-05	0.000209	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC5A5—ovarian cancer	1.32e-05	0.000209	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—ovarian cancer	1.31e-05	0.000137	CcSEcCtD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	1.31e-05	0.000208	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.31e-05	0.000208	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.3e-05	0.000207	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.3e-05	0.000207	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	1.29e-05	0.000205	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.29e-05	0.000205	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CAV1—ovarian cancer	1.28e-05	0.000203	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC2A1—ovarian cancer	1.28e-05	0.000203	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC2A1—ovarian cancer	1.27e-05	0.000202	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—FASN—ovarian cancer	1.26e-05	0.0002	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	1.25e-05	0.000199	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.25e-05	0.000199	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—ovarian cancer	1.25e-05	0.000199	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.25e-05	0.000198	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC5A5—ovarian cancer	1.24e-05	0.000197	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1B1—ovarian cancer	1.23e-05	0.000195	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—ovarian cancer	1.23e-05	0.000195	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1B1—ovarian cancer	1.22e-05	0.000194	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—ovarian cancer	1.22e-05	0.000194	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—ovarian cancer	1.21e-05	0.000192	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.21e-05	0.000192	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TYMS—ovarian cancer	1.2e-05	0.000191	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.2e-05	0.00019	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC2A1—ovarian cancer	1.19e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	1.18e-05	0.000188	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—ovarian cancer	1.17e-05	0.000186	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—ovarian cancer	1.17e-05	0.000185	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—ovarian cancer	1.16e-05	0.000185	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.16e-05	0.000184	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—ovarian cancer	1.15e-05	0.000184	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1B1—ovarian cancer	1.15e-05	0.000182	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.13e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.13e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.13e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.13e-05	0.000179	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—ovarian cancer	1.12e-05	0.000177	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—ovarian cancer	1.11e-05	0.000177	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.11e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.1e-05	0.000174	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPP2R1A—ovarian cancer	1.09e-05	0.000173	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.08e-05	0.000172	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—YAP1—ovarian cancer	1.08e-05	0.000172	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPP2R1A—ovarian cancer	1.08e-05	0.000172	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.08e-05	0.000171	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.07e-05	0.00017	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.07e-05	0.000169	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—ovarian cancer	1.04e-05	0.000166	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—ovarian cancer	1.04e-05	0.000165	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.03e-05	0.000164	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CD—ovarian cancer	1.02e-05	0.000163	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.02e-05	0.000162	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.02e-05	0.000162	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—ovarian cancer	1.02e-05	0.000162	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPP2R1A—ovarian cancer	1.02e-05	0.000161	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.01e-05	0.000161	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—ovarian cancer	1.01e-05	0.00016	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—ovarian cancer	1e-05	0.000159	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—ovarian cancer	1e-05	0.000159	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TYMS—ovarian cancer	9.91e-06	0.000158	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TYMS—ovarian cancer	9.85e-06	0.000157	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	9.8e-06	0.000156	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK1—ovarian cancer	9.79e-06	0.000156	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.78e-06	0.000156	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CAV1—ovarian cancer	9.7e-06	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	9.59e-06	0.000152	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK3—ovarian cancer	9.58e-06	0.000152	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK3—ovarian cancer	9.52e-06	0.000151	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—ovarian cancer	9.43e-06	0.00015	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	9.32e-06	0.000148	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—ovarian cancer	9.32e-06	0.000148	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	9.32e-06	0.000148	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMS—ovarian cancer	9.26e-06	0.000147	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—ovarian cancer	9.26e-06	0.000147	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK3—ovarian cancer	9.2e-06	0.000146	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK1—ovarian cancer	9.12e-06	0.000145	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK1—ovarian cancer	9.06e-06	0.000144	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—ovarian cancer	8.95e-06	0.000142	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CB—ovarian cancer	8.93e-06	0.000142	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	8.92e-06	0.000142	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—ovarian cancer	8.89e-06	0.000141	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NME2—ovarian cancer	8.84e-06	0.00014	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—ovarian cancer	8.84e-06	0.00014	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FASN—ovarian cancer	8.82e-06	0.00014	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—ovarian cancer	8.81e-06	0.00014	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK1—ovarian cancer	8.75e-06	0.000139	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—ovarian cancer	8.67e-06	0.000138	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.56e-06	0.000136	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	8.51e-06	0.000135	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC2A1—ovarian cancer	8.38e-06	0.000133	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	8.37e-06	0.000133	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—ovarian cancer	8.33e-06	0.000132	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1B1—ovarian cancer	8.03e-06	0.000128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAV1—ovarian cancer	7.99e-06	0.000127	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—ovarian cancer	7.98e-06	0.000127	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—ovarian cancer	7.95e-06	0.000126	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAV1—ovarian cancer	7.94e-06	0.000126	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	7.91e-06	0.000126	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—ovarian cancer	7.77e-06	0.000123	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—ovarian cancer	7.72e-06	0.000123	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—ovarian cancer	7.65e-06	0.000122	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—ovarian cancer	7.61e-06	0.000121	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—ovarian cancer	7.61e-06	0.000121	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAV1—ovarian cancer	7.46e-06	0.000119	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—ovarian cancer	7.35e-06	0.000117	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	7.33e-06	0.000117	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—ovarian cancer	7.28e-06	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—ovarian cancer	7.23e-06	0.000115	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—ovarian cancer	7.2e-06	0.000114	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—ovarian cancer	7.13e-06	0.000113	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPP2R1A—ovarian cancer	7.12e-06	0.000113	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	7.06e-06	0.000112	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	7.02e-06	0.000112	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	6.97e-06	0.000111	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	6.83e-06	0.000109	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—ovarian cancer	6.8e-06	0.000108	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—ovarian cancer	6.77e-06	0.000108	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	6.68e-06	0.000106	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—ovarian cancer	6.61e-06	0.000105	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK3—ovarian cancer	6.55e-06	0.000104	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—ovarian cancer	6.4e-06	0.000102	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—ovarian cancer	6.37e-06	0.000101	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—ovarian cancer	6.36e-06	0.000101	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK3—ovarian cancer	6.28e-06	9.98e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK1—ovarian cancer	6.24e-06	9.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	6.14e-06	9.76e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—ovarian cancer	6.11e-06	9.71e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—ovarian cancer	5.98e-06	9.5e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK1—ovarian cancer	5.97e-06	9.5e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—ovarian cancer	5.85e-06	9.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.71e-06	9.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYTB—ovarian cancer	5.69e-06	9.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	5.69e-06	9.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	5.58e-06	8.86e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—ovarian cancer	5.58e-06	8.86e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—ovarian cancer	5.54e-06	8.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.52e-06	8.77e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—ovarian cancer	5.45e-06	8.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.43e-06	8.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.37e-06	8.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.24e-06	8.33e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—ovarian cancer	5.23e-06	8.32e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAV1—ovarian cancer	5.23e-06	8.32e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—ovarian cancer	5.21e-06	8.28e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—ovarian cancer	5.01e-06	7.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BRIP1—ovarian cancer	4.98e-06	7.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPP1CC—ovarian cancer	4.98e-06	7.91e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—ovarian cancer	4.82e-06	7.66e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—ovarian cancer	4.79e-06	7.61e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—ovarian cancer	4.77e-06	7.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.73e-06	7.52e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—ovarian cancer	4.5e-06	7.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.48e-06	7.11e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—ovarian cancer	4.45e-06	7.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.35e-06	6.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.26e-06	6.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.26e-06	6.77e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—ovarian cancer	4.19e-06	6.66e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—ovarian cancer	4.13e-06	6.56e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.02e-06	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.7e-06	5.87e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—ovarian cancer	3.65e-06	5.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.57e-06	5.68e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—ovarian cancer	3.4e-06	5.4e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—ovarian cancer	3.38e-06	5.37e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—ovarian cancer	3.37e-06	5.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—YAP1—ovarian cancer	3.34e-06	5.31e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—ovarian cancer	3.18e-06	5.05e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—ovarian cancer	3.16e-06	5.02e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—ovarian cancer	2.78e-06	4.41e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—ovarian cancer	2.76e-06	4.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FASN—ovarian cancer	2.72e-06	4.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—ovarian cancer	2.68e-06	4.25e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—ovarian cancer	2.59e-06	4.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A1—ovarian cancer	2.58e-06	4.11e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1B1—ovarian cancer	2.48e-06	3.94e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—ovarian cancer	2.23e-06	3.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.2e-06	3.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—ovarian cancer	2e-06	3.19e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—ovarian cancer	1.82e-06	2.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAV1—ovarian cancer	1.62e-06	2.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.47e-06	2.34e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.29e-06	2.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.13e-06	1.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—ovarian cancer	9.74e-07	1.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—ovarian cancer	6.87e-07	1.09e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—ovarian cancer	5.61e-07	8.92e-06	CbGpPWpGaD
